CN103173518A - Kit for detecting lipase by enzyme method and preparation method - Google Patents

Kit for detecting lipase by enzyme method and preparation method Download PDF

Info

Publication number
CN103173518A
CN103173518A CN 201110430794 CN201110430794A CN103173518A CN 103173518 A CN103173518 A CN 103173518A CN 201110430794 CN201110430794 CN 201110430794 CN 201110430794 A CN201110430794 A CN 201110430794A CN 103173518 A CN103173518 A CN 103173518A
Authority
CN
China
Prior art keywords
reagent
deionized water
cumulative volume
test kit
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 201110430794
Other languages
Chinese (zh)
Inventor
景晟
孙卫兵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Fosun Changzheng Medical Science Co Ltd
Shanghai Fosun Pharmaceutical Group Co Ltd
Original Assignee
Shanghai Fosun Changzheng Medical Science Co Ltd
Shanghai Fosun Pharmaceutical Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Fosun Changzheng Medical Science Co Ltd, Shanghai Fosun Pharmaceutical Group Co Ltd filed Critical Shanghai Fosun Changzheng Medical Science Co Ltd
Priority to CN 201110430794 priority Critical patent/CN103173518A/en
Publication of CN103173518A publication Critical patent/CN103173518A/en
Pending legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention provides a kit for detecting lipase by an enzyme method, and is composed of a reagent 1 and a reagent 2. The reagent 1 is composed of 10-200mmol/L of 2L buffer, 0.01-20ml/L of sodium deoxycholate, 0.1-2mg/L of colipase, 5-20mmol/L of calcium chloride, 0.5-2g/L of sodium azide, and the balance of deionized water to 2L; and the reagent 2 comprises the following components by weight: 10-200mmol/L of 1L tartrate, 0.1-10mmol/L of bezoar sodium deoxycholate, 10-200mmol/L of mannitol, 0.01-0.5ml/L of proclin300, 10-200mmol/L of mercaptoacetic acid, 0.1-0.5mmol/L of 6-methyl resorufin, and the balance of deionized water to 1L. The kit has strong protection effect on a substrate, and the stability of the reagent is increased, the kit has good detection effect, and has large clinical application value.

Description

Enzyme process detects lipase test kit and preparation method thereof
Technical field
The present invention relates to biological reagent, be specifically related to a kind of detection kit, relate in particular to a kind of enzyme process and detect lipase test kit and preparation method thereof.
Background technology
Lipase (Lipase EC3.1.1.3., LPS, GEH) is the enzyme of a class hydrolysis grease.The hydrolysis substrate of lipase is generally natural fats and oils, and it is hydrolyzed the position is the ester bond that in grease, lipid acid is connected with glycerine.It is different from other lytic enzyme, lipase-catalyzed action system is a kind of nonhomogeneous system, water miscible enzyme catalysis occurs on the interface of water insoluble substrates and water, katalysis mechanism on this interface is very unclear, can not be simply with the reaction mechanism between Michaelis2Menten theory explain enzyme-to-substrate.Someone has proposed the hypothesis that lipase is located on oil-water interface, proposed the model of " super substrate ", and this model can be explained some behaviors of lipase, but also needs further experimental results show that and revise.In addition, lipase is active with reverse catalyzing glycerol and free fatty acids synthetic glycerine fat.Lipase is in clinical meaning: normal human blood LPS content is few, but when acute pancreatitis, 2~12h blood LPS significantly raises, 24h can reach 10 times of Upper Limit of Normal Value to peak value, even 50 times, may recover normally to 48~72h, but sustainable rising 8~15 days again subsequently.Due to blood LPS when the acute pancreatitis the active time that raises early, the amplitude of rising large, the time that continues is long, therefore its diagnostic value is better than amylase.Clinical observation is found, the case that all blood AMY raise, and its LPS all raises; And LPS rising person AMY not necessarily raises, and the normal pancreatitis patient of 2/3AMY is approximately arranged, and its LPS is normal; Non-pancreatitic acute abdomen has blood AMY to raise and LPS does not raise.The blood LPS such as excessive drinking, ethanol pancreatitis, chronic pancreatitis, carcinoma of the pancreas, hepatobiliary disease can have rising in various degree.The method of measuring so far LPS can be divided into 3 classes: 1. measure the increase (as volumetry, colorimetry, spectrophotometry, fluorescent method and pH electrode method etc.) of product (free fatty acids); 2. measure the reduction (as turbidimetry, diffusion process etc.) of substrate; 3. measure the actual mass (double-antibody sandwich immunoassay method, latex agglutination) of LPS.At present at home mostly the laboratory mainly take volumetry, turbidimetry and spectrophotometry as main.Spectrophotometry has two classes more commonly used at present: 1. enzyme coupling colour developing colorimetry, multiplex 1, the 2-triglyceride is substrate, under the catalysis of LPS and monoglyceride lipase, hydrolysis generates glycerine and lipid acid, glycerine generates glycerol 3-phosphate by the glycerol kinase effect, then produces red-purple by GPO/peroxidase system and 4-AAP chromogen system.Variation in 550nm wavelength continuous monitoring absorbancy can be calculated the LPS activity.This class methods specificity is high, also substantially can solve the interference problem of endogenous glycerine by double reagent.2. 1, the continuous monitoring method of 2-o-two bays-racemize-glycerine-3-valeric acid-(6-methyl resorufin) ester design.This substrate is in alkaline environment, and under LPS and colipase effect, hydrolysis generates 1,2-O-dilauryl glycerine and pentanedioic acid-6 '-methyl resorufin.The latter is unstable, but Auto-decomposition generates pentanedioic acid and methyl resorufin.The methyl resorufin has absorption peak at 581nm wavelength place, but that its absorbancy of continuous monitoring changes quantitative assay LPS is active.This method has easy, quick, sensitive, stable and the characteristics such as immunity from interference is strong.But enzyme coupling development process, toolenzyme expensive, and also enzyme source is few and unstable, producer is seldom arranged in this way.Substrate hydrolysis method, substrate are extremely unstable, and what the background of reagent raise is exceedingly fast, and causes reagent to calibrate every day.Waste reagent is also wasted calibration object.And can cause the inaccurate of result.Therefore demand seeking better detection method urgently.
Summary of the invention
Technical problem to be solved by this invention is to overcome above-mentioned weak point, and the synthetic substrate of research and design stabilised fat enzyme improves reagent stability, for detection of the reagent of lipase.
The invention provides a kind of enzyme process and detect the lipase test kit, this test kit is by following reagent 1 and reagent 2, in 1 part: the ratio of 1 part forms:
Reagent 1:(2L) (reagent volume)
Figure BDA0000122632370000031
Reagent 2:(1L) (reagent volume)
Figure BDA0000122632370000032
It is 1L that deionized water adds to cumulative volume.
Described reagent 1 damping fluid is selected from TRIS (Tutofusin tris tris (hydroxymethyl) aminomethane), MOPS (3-(N-morpholine) propanesulfonic acid 3-(N-morpholino) propanesulfonic acid), BICINE (N, N-two (2-hydroxyethyl glycine) or HEPES (4-hydroxyethyl piperazine ethanesulfonic acid 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid).
The present invention detects the lipase test kit, and in use, reagent 1 adds reagent 2 after adding the detection sample again, can detect.
Another object of the present invention has been to provide the preparation method of lipase test kit: the method comprises the following steps:
(1) preparation reagent 1:(2L) (reagent volume)
(1) first be incorporated as the deionized water of total amount 80% in the container;
(2) add successively damping fluid, Sodium desoxycholate, calcium chloride, sodium azide;
(3) add colipase;
(4) adding at last deionized water to the cumulative volume of residual content is that 2L mixes, and get final product;
(2) preparation reagent 2:(1L) (reagent volume)
Add successively cow-bezoar Sodium desoxycholate, N.F,USP MANNITOL, proclin300 (biological preservative), Thiovanic acid, 6-methyl resorufin in container, it is that 1L mixes that deionized water adds to cumulative volume, and get final product.
The inventor is through research trial, added Substrate Protection agent N.F,USP MANNITOL and Thiovanic acid in test kit, wherein agent has no bibliographical information to Thiovanic acid as Substrate Protection, although, N.F,USP MANNITOL has the removal Free Radical, can reach the protective material effect but must use just together with Thiovanic acid; On the other hand, if N.F,USP MANNITOL does not add, Thiovanic acid self just is easy to oxidation and hydrolysis.After the present invention has added Substrate Protection agent N.F,USP MANNITOL and Thiovanic acid, guaranteed the stability of reagent.
Test kit of the present invention detects effective, and the substrate of the synthetic in reagent is had very strong provide protection, and is As time goes on more obvious to the provide protection meeting of substrate, and larger clinical value is arranged.
Embodiment
Following examples agents useful for same raw material all obtains by commercially available.
Figure BDA0000122632370000051
Embodiment 1 preparation lipase detection kit
Form:
Reagent 1:(2L) (reagent volume)
It is 2L that deionized water adds to cumulative volume;
Reagent 2:(1L) (reagent volume)
Figure BDA0000122632370000053
Figure BDA0000122632370000061
It is 1L that deionized water adds to cumulative volume.
Preparation:
(1) preparation reagent 1:(2L)
(1) first add the deionized water of 1.6L in the container;
(2) add successively TRIS damping fluid, Sodium desoxycholate, calcium chloride, sodium azide;
(3) add enzyme: colipase
(4) adding at last deionized water to cumulative volume is that 2L mixes, and get final product;
(2) preparation reagent 2:(1L)
Adding successively tartrate, cow-bezoar Septochol, N.F,USP MANNITOL proclin300 (biological preservative), Thiovanic acid, 6-methyl resorufin, deionized water to add to cumulative volume in the container is 2L, mixes.
Embodiment 2
Reagent 1:(2L)
Figure BDA0000122632370000062
It is 2L that deionized water adds to cumulative volume.
Reagent 2:(1L)
Figure BDA0000122632370000071
It is 1L that deionized water adds to cumulative volume.
Embodiment 3
Reagent 1:(2L)
Figure BDA0000122632370000072
It is 2L that deionized water adds to cumulative volume.
Reagent 2:(1L)
It is 1L that deionized water adds to cumulative volume.
The preparation method is with embodiment 1
Embodiment 4
The test kit of the embodiment of the present invention 1 detects effect test:
Measuring method:
Step 1: input parameter is in automatic biochemistry analyzer: 37 ℃ of temperature, and predominant wavelength 583nm, commplementary wave length 800nm,
R1 300ul (embodiment 1 reagent 1) .R2150ul (embodiment 1 reagent 2).
Contrast agents: Switzerland Luo Shi lipase test kit (reagent 1300ul; Reagent 2150ul does not wherein add N.F,USP MANNITOL, Thiovanic acid) manufacturer (Switzerland Roche Holding Ag);
Detect sample 4ul (serum sample)
Reading point: 16-24
Step 2: before measuring with R1 and R2 balance to room temperature., then put into agent bin
Step 3 input scaling ratio: 2218
In use, reagent 1 adds reagent 2 after adding the detection sample again, can detect.
(1) embodiment 1 reagent with N.F,USP MANNITOL, Thiovanic acid as the impact on detection reaction of protective material and sample reagent
(2) embodiment 1 reagent and the sample reagent provide protection to substrate
Figure BDA0000122632370000091
Above-mentioned detected result shows that test kit of the present invention adds N.F,USP MANNITOL and Thiovanic acid to the substrate in reagent, very strong provide protection to be arranged; As time goes on; can be more obvious to Protection of Substrates; add protectant reagent after 12 months and do not add protectant reagent and compare; the reagent background has only raise 10%, and the reagent background of sample reagent box has raise 10 times.
The clinical correlation comparison test of embodiment 5 and Luo Shi lipase test kit
The present embodiment 1 test kit and Luo Shi lipase test kit have been made clinical correlation relatively:
Get the clinical sample and parallel detection of the commercially available Luo Shi test kit that obtains (reagent 1:2*80ml reagent 2:16*10ml) manufacturer (Switzerland Roche Holding Ag) of 30 routine different concns
Use instrument: Olympus 400
Measuring method
Step 1: input parameter is in automatic biochemistry analyzer: 37 ℃ of temperature, and predominant wavelength 583nm, auxiliary wavelength 800nm,
In use, reagent 1 adds reagent 2 after adding the detection sample again, can detect.
Contrast agents: Switzerland Luo Shi lipase test kit (reagent 1300ul; Reagent 2150ul does not wherein add N.F,USP MANNITOL, Thiovanic acid) manufacturer (Switzerland Roche Holding Ag);
Detect sample 4ul (serum sample)
Reading point: 16-24
Step 2: before measuring with R1 and R2 balance to room temperature., then put into agent bin
Step 3 input scaling ratio: 2218
The above parameter of input on Olympus 400, in use, reagent 1 adds reagent 2 after adding the detection sample again, can detect.
Test-results:
Figure BDA0000122632370000101
Figure BDA0000122632370000111
According to top clinical comparison data, this reagent is good with the clinical correlation of Luo Shi reagent, there is no difference.Can for clinical, reduce medical expense.
Embodiment 6
Reagent 1:(2L)
Figure BDA0000122632370000121
It is 2L that deionized water adds to cumulative volume.
Reagent 2:(1L)
Figure BDA0000122632370000122
It is 1L that deionized water adds to cumulative volume.
The preparation method is with embodiment 1.
Embodiment 7
Reagent 1:(2L)
Figure BDA0000122632370000123
Figure BDA0000122632370000131
It is 2L that deionized water adds to cumulative volume.
Reagent 2:(1L)
It is 1L that deionized water adds to cumulative volume.
The preparation method is with embodiment 1.

Claims (3)

1. an enzyme process detects the lipase test kit, it is characterized in that, described test kit by following reagent 1 and reagent 2 in 1 part: the ratio of 1 part forms:
Reagent 1:2L
It is 2L that deionized water adds to cumulative volume
Reagent 2:1L
It is 1L that deionized water adds to cumulative volume.
2. enzyme process detects the lipase test kit according to claim 1, it is characterized in that, the damping fluid of described reagent 1 is selected from TRIS, MOPS or HEPES.
One kind as claimed in claim 1 enzyme process detect the preparation method of lipase test kit, it is characterized in that, described test kit by following reagent 1 and reagent 2 in 1 part: the ratio of 1 part forms:
Reagent 1:2L
Figure FDA0000122632360000021
It is 2L that deionized water adds to cumulative volume
Reagent 2:1L
Figure FDA0000122632360000022
It is 1L that deionized water adds to cumulative volume
Described preparation method comprises the following steps:
(1) preparation reagent 1:2L
(1) first be incorporated as the deionized water of total amount 80% in the container;
(2) add successively damping fluid, Sodium desoxycholate, calcium chloride, sodium azide;
(3) add colipase;
(4) adding at last deionized water to cumulative volume is 2L, mixes, and get final product;
(2) preparation reagent 2:1L
Add successively cow-bezoar Sodium desoxycholate, N.F,USP MANNITOL, proclin300, Thiovanic acid, 6-methyl resorufin in container, it is 1L that deionized water adds to cumulative volume,
Mix, and get final product.
CN 201110430794 2011-12-20 2011-12-20 Kit for detecting lipase by enzyme method and preparation method Pending CN103173518A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110430794 CN103173518A (en) 2011-12-20 2011-12-20 Kit for detecting lipase by enzyme method and preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110430794 CN103173518A (en) 2011-12-20 2011-12-20 Kit for detecting lipase by enzyme method and preparation method

Publications (1)

Publication Number Publication Date
CN103173518A true CN103173518A (en) 2013-06-26

Family

ID=48633706

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110430794 Pending CN103173518A (en) 2011-12-20 2011-12-20 Kit for detecting lipase by enzyme method and preparation method

Country Status (1)

Country Link
CN (1) CN103173518A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104215632A (en) * 2014-08-28 2014-12-17 宁波瑞源生物科技有限公司 Stable lipase kit
CN105755103A (en) * 2014-12-16 2016-07-13 上海复星长征医学科学有限公司 Reagent for measuring lipase activity by stable enzymic method
CN107782680A (en) * 2016-08-26 2018-03-09 山东博科生物产业有限公司 A kind of antiheparin fat enzyme detection kit of stabilization
CN109490296A (en) * 2018-12-29 2019-03-19 南京澳林生物科技有限公司 A kind of fat enzyme detection kit and production technology
CN109580515A (en) * 2019-01-14 2019-04-05 中生北控生物科技股份有限公司 A kind of reagent and the preparation method and application thereof measured for pancreatic lipase in serum or blood plasma
CN110923292A (en) * 2019-11-15 2020-03-27 中山市创艺生化工程有限公司 Serum lipase detection kit and preparation method and application thereof
CN112051354A (en) * 2020-08-05 2020-12-08 武汉生之源生物科技股份有限公司 Lipase determination kit and preparation method thereof

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104215632A (en) * 2014-08-28 2014-12-17 宁波瑞源生物科技有限公司 Stable lipase kit
CN104215632B (en) * 2014-08-28 2017-12-19 宁波瑞源生物科技有限公司 A kind of fatty enzyme reagent kit of stabilization
CN105755103A (en) * 2014-12-16 2016-07-13 上海复星长征医学科学有限公司 Reagent for measuring lipase activity by stable enzymic method
CN107782680A (en) * 2016-08-26 2018-03-09 山东博科生物产业有限公司 A kind of antiheparin fat enzyme detection kit of stabilization
CN109490296A (en) * 2018-12-29 2019-03-19 南京澳林生物科技有限公司 A kind of fat enzyme detection kit and production technology
CN109490296B (en) * 2018-12-29 2021-07-20 南京澳林生物科技有限公司 Lipase detection kit and production process
CN109580515A (en) * 2019-01-14 2019-04-05 中生北控生物科技股份有限公司 A kind of reagent and the preparation method and application thereof measured for pancreatic lipase in serum or blood plasma
CN110923292A (en) * 2019-11-15 2020-03-27 中山市创艺生化工程有限公司 Serum lipase detection kit and preparation method and application thereof
CN110923292B (en) * 2019-11-15 2024-03-29 中山市创艺生化工程有限公司 Serum lipase detection kit and preparation method and application thereof
CN112051354A (en) * 2020-08-05 2020-12-08 武汉生之源生物科技股份有限公司 Lipase determination kit and preparation method thereof
CN112051354B (en) * 2020-08-05 2022-06-14 武汉生之源生物科技股份有限公司 Lipase determination kit and preparation method thereof

Similar Documents

Publication Publication Date Title
CN103173518A (en) Kit for detecting lipase by enzyme method and preparation method
CN104215632B (en) A kind of fatty enzyme reagent kit of stabilization
Tietz et al. Lipase in serum--the elusive enzyme: an overview
Sturk et al. Macro enzymes: prevalence, composition, detection and clinical relevance
Fletcher et al. Associations between PFOA, PFOS and changes in the expression of genes involved in cholesterol metabolism in humans
Malhotra et al. Alkaline phosphatase as a periodontal disease marker
Reif et al. Matrix metalloproteinases 2 and 9 are markers of inflammation but not of the degree of fibrosis in chronic hepatitis C
CN104198474A (en) Detection kit for measuring content of lipase in serum by colorimetric method
Foo et al. Amylase measurement with 2-chloro-4-nitrophenyl maltotrioside as substrate
CN105241873B (en) A kind of fat enzyme detection kit
Pundir Construction of an amperometric enzymic sensor for triglyceride determination
CN108287233A (en) A kind of enzyme process uric acid detection reagent of strong antijamming capability
CN107796941A (en) The measure kit and its detection method of a kind of platelet-activating factor acetylhydro-lase
Tietz et al. Laboratory tests in the differential diagnosis of hyperamylasemia.
Brignot et al. Oral lipolysis and its association with diet and the perception and digestion of lipids: A systematic literature review
CN104048929A (en) Detection kit for total bilirubin
CN105203533B (en) A kind of high N acetyl β D UNAG detection reagents of sensitivity for analysis
Siggins et al. Quantitation of the active and low-active forms of human plasma phospholipid transfer protein by ELISA
CN104730014B (en) A kind of serum lipase determination kit and preparation method thereof
CN107782680A (en) A kind of antiheparin fat enzyme detection kit of stabilization
CN101975753B (en) Two-step enzymatic determination method for cholesterol ester in serum
CN109490227A (en) A kind of highly sensitive fatty enzyme reagent kit
Deborde et al. Placental GPI-PLD is of maternal origin and its GPI substrate is absent from placentae of pregnancies associated with pre-eclampsia
Ali et al. Sequence and structure-based method to predict diacylglycerol lipases in protein sequence
Roe et al. Determination and clinical significance of serum lipase

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130626